The Effect of Thiamine and Vitamin C Combination on Mortality Rate of Patients with Severe Sepsis: A Randomized Control Clinical Trial Study
Background: Sepsis is a potentially life-threatening condition characterized by the body's deregulated response to infection, in turn causing injury to its own tissues and organs. The present study investigated the effect of co-administration of thiamine and vitamin C on reducing mortality in p...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | fas |
| Published: |
Isfahan University of Medical Sciences
1401-09-01
|
| Series: | مجله دانشکده پزشکی اصفهان |
| Subjects: | |
| Online Access: | https://jims.mui.ac.ir/article_26275_713b521d4d5b06f9cda40ebb149b0d5e.pdf |
| _version_ | 1797704059528937472 |
|---|---|
| author | Kiana Shirani Rasool Soltani Yasaman Eskandari Hasan Salehi |
| author_facet | Kiana Shirani Rasool Soltani Yasaman Eskandari Hasan Salehi |
| author_sort | Kiana Shirani |
| collection | DOAJ |
| description | Background: Sepsis is a potentially life-threatening condition characterized by the body's deregulated response to infection, in turn causing injury to its own tissues and organs. The present study investigated the effect of co-administration of thiamine and vitamin C on reducing mortality in patients with severe sepsis.Methods: In this randomized clinical trial study, 86 patients with severe sepsis were assigned to treatment and control groups, each comprising 43 patients. The treatment group received thiamine 600 mg orally every 12 hours and vitamin C at a dose of 50 mg / kg, intravenously daily for 96 hours alongside standard treatment and the control group received standard treatment. Therapeutic outcome (recovery or death), duration of hospitalization and duration of ventilator connection were recorded for patients in both groups. Also, procalcitonin level (PCT) and CRP levels were measured and recorded at the beginning and after 96 hours.Findings: The odds ratio of death outcome in the treatment group was significantly lower than the control group (0.913-0.116: 95% CI, P = 0.033, OR = 0.32). The mean length of hospital stay in the treatment group was about 7 days that was less than the control group significantly. The mean length of ICU hospitalization in the treatment group was less than the control group significantly too.Conclusion: Co-administration of vitamin C and thiamine in sepsis patients can reduce the length of hospital stay in the intensive care unit and hospital and also reduce the serum level of inflammatory factors and reduce the rate of death in these patients. |
| first_indexed | 2024-03-12T05:13:46Z |
| format | Article |
| id | doaj.art-7314461cebbe4879a120d29e010f984d |
| institution | Directory Open Access Journal |
| issn | 1027-7595 1735-854X |
| language | fas |
| last_indexed | 2024-03-12T05:13:46Z |
| publishDate | 1401-09-01 |
| publisher | Isfahan University of Medical Sciences |
| record_format | Article |
| series | مجله دانشکده پزشکی اصفهان |
| spelling | doaj.art-7314461cebbe4879a120d29e010f984d2023-09-03T08:22:20ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X1401-09-014069182583110.48305/jims.v40.i691.082526275The Effect of Thiamine and Vitamin C Combination on Mortality Rate of Patients with Severe Sepsis: A Randomized Control Clinical Trial StudyKiana Shirani0Rasool Soltani1Yasaman Eskandari2Hasan Salehi3Assistant Professor, Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, IranProfessor, Department of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, IranResident, Department of Infectious Diseases and Tropical Medicine, Isfahan University of Medical Sciences, Isfahan, IranProfessor, Department of Infectious Diseases and Tropical Medicine, School of Medicine, Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, IranBackground: Sepsis is a potentially life-threatening condition characterized by the body's deregulated response to infection, in turn causing injury to its own tissues and organs. The present study investigated the effect of co-administration of thiamine and vitamin C on reducing mortality in patients with severe sepsis.Methods: In this randomized clinical trial study, 86 patients with severe sepsis were assigned to treatment and control groups, each comprising 43 patients. The treatment group received thiamine 600 mg orally every 12 hours and vitamin C at a dose of 50 mg / kg, intravenously daily for 96 hours alongside standard treatment and the control group received standard treatment. Therapeutic outcome (recovery or death), duration of hospitalization and duration of ventilator connection were recorded for patients in both groups. Also, procalcitonin level (PCT) and CRP levels were measured and recorded at the beginning and after 96 hours.Findings: The odds ratio of death outcome in the treatment group was significantly lower than the control group (0.913-0.116: 95% CI, P = 0.033, OR = 0.32). The mean length of hospital stay in the treatment group was about 7 days that was less than the control group significantly. The mean length of ICU hospitalization in the treatment group was less than the control group significantly too.Conclusion: Co-administration of vitamin C and thiamine in sepsis patients can reduce the length of hospital stay in the intensive care unit and hospital and also reduce the serum level of inflammatory factors and reduce the rate of death in these patients.https://jims.mui.ac.ir/article_26275_713b521d4d5b06f9cda40ebb149b0d5e.pdfascorbic acidmortalityprocalcitoninsepsisthiamine |
| spellingShingle | Kiana Shirani Rasool Soltani Yasaman Eskandari Hasan Salehi The Effect of Thiamine and Vitamin C Combination on Mortality Rate of Patients with Severe Sepsis: A Randomized Control Clinical Trial Study مجله دانشکده پزشکی اصفهان ascorbic acid mortality procalcitonin sepsis thiamine |
| title | The Effect of Thiamine and Vitamin C Combination on Mortality Rate of Patients with Severe Sepsis: A Randomized Control Clinical Trial Study |
| title_full | The Effect of Thiamine and Vitamin C Combination on Mortality Rate of Patients with Severe Sepsis: A Randomized Control Clinical Trial Study |
| title_fullStr | The Effect of Thiamine and Vitamin C Combination on Mortality Rate of Patients with Severe Sepsis: A Randomized Control Clinical Trial Study |
| title_full_unstemmed | The Effect of Thiamine and Vitamin C Combination on Mortality Rate of Patients with Severe Sepsis: A Randomized Control Clinical Trial Study |
| title_short | The Effect of Thiamine and Vitamin C Combination on Mortality Rate of Patients with Severe Sepsis: A Randomized Control Clinical Trial Study |
| title_sort | effect of thiamine and vitamin c combination on mortality rate of patients with severe sepsis a randomized control clinical trial study |
| topic | ascorbic acid mortality procalcitonin sepsis thiamine |
| url | https://jims.mui.ac.ir/article_26275_713b521d4d5b06f9cda40ebb149b0d5e.pdf |
| work_keys_str_mv | AT kianashirani theeffectofthiamineandvitaminccombinationonmortalityrateofpatientswithseveresepsisarandomizedcontrolclinicaltrialstudy AT rasoolsoltani theeffectofthiamineandvitaminccombinationonmortalityrateofpatientswithseveresepsisarandomizedcontrolclinicaltrialstudy AT yasamaneskandari theeffectofthiamineandvitaminccombinationonmortalityrateofpatientswithseveresepsisarandomizedcontrolclinicaltrialstudy AT hasansalehi theeffectofthiamineandvitaminccombinationonmortalityrateofpatientswithseveresepsisarandomizedcontrolclinicaltrialstudy AT kianashirani effectofthiamineandvitaminccombinationonmortalityrateofpatientswithseveresepsisarandomizedcontrolclinicaltrialstudy AT rasoolsoltani effectofthiamineandvitaminccombinationonmortalityrateofpatientswithseveresepsisarandomizedcontrolclinicaltrialstudy AT yasamaneskandari effectofthiamineandvitaminccombinationonmortalityrateofpatientswithseveresepsisarandomizedcontrolclinicaltrialstudy AT hasansalehi effectofthiamineandvitaminccombinationonmortalityrateofpatientswithseveresepsisarandomizedcontrolclinicaltrialstudy |